Recent findings suggesting the potential transdiagnostic efficacy of psychedelic-assisted
therapy have fostered the need to deepen our understanding of psychedelic brain action …

Psychedelic therapy has witnessed a resurgence in interest in the last decade from the
scientific and medical communities with evidence now building for its safety and efficacy in …

N, N-Dimethyltryptamine (DMT) is a serotonergic psychedelic that induces a rapid and
transient altered state of consciousness when inhaled or injected via bolus administration …

Background Pharmacological and nonpharmacological methods of inducing altered states
of consciousness (ASCs) are becoming increasingly relevant in the treatment of psychiatric …

Modern psychedelic research and clinical development is at a crucial inflection point, with
great potential for the treatment of many mental illnesses demonstrated but significant …

Psychedelic therapy (PT) is an emerging paradigm with great transdiagnostic potential for
treating psychiatric disorders, including depression, addiction, post-traumatic stress …

The emerging neuroscientific frontier of brain fingerprinting has recently established that
human functional connectomes (FCs) exhibit fingerprint-like idiosyncratic features, which …

New Psychoactive Substances (NPS) are modifying the drug scenario worldwide and have
become a public health concern because of their toxicological profiles and their harmful …

The rewarding effects of stimulant drugs such as methylphenidate (MP) depend crucially on
how fast they raise dopamine in the brain. Yet how the rate of drug-induced dopamine …

Neural activity and behavior manifest state and trait dynamics, as well as variation within
and between individuals. However, the mapping of state-trait neural variation to behavior is …